Recursion Pharmaceuticals (RXRX) Gross Profit (2021 - 2026)
Recursion Pharmaceuticals (RXRX) recorded Gross Profit of -$3.82 million in Q2 2026, compared with -$938,000 a year earlier.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Gross Profit (2021 - 2026) Analysis & Trends
On a TTM basis, Recursion Pharmaceuticals' Gross Profit came in at $1.91 million as of Jun 30, 2026; for FY2025, it was $3.73 million, down 72.6% from FY2024.
- Annual Gross Profit has a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $13.6 million in FY2024 (+584.2%), $1.99 million in FY2023, -$8.43 million in FY2022 and $10.18 million in FY2021 (+156.9%).
- Quarterly Gross Profit has ranged from -$9.51 million in Q3 2025 to $21.26 million in Q4 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$6.02 million (Q1 2026), $21.26 million (Q4 2025) and -$9.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Recursion Pharmaceuticals | 2.21 Bn | -397.37 Mn | -3.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.82 Mn |
| Mar 31, 2026 | -6.02 Mn |
| Dec 31, 2025 | 21.26 Mn |
| Sep 30, 2025 | -9.51 Mn |
| Jun 30, 2025 | -938,000.00 |
| Mar 31, 2025 | -7.08 Mn |
| Dec 31, 2024 | -8.25 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 5.22 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | -344,000.00 |
| Jun 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | -314,000.00 |
| Dec 31, 2022 | 2.84 Mn |
| Sep 30, 2022 | -2.25 Mn |
| Jun 30, 2022 | -6.55 Mn |
| Mar 31, 2022 | -2.47 Mn |
| Dec 31, 2021 | 2.53 Mn |
| Sep 30, 2021 | 2.53 Mn |
API Access
Recursion Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();